Metabolic outcomes GLP-1RAs consistently yield significant weight loss and glycemic control in patients with IBD and comorbid obesity or diabetes
To learn more, Sinaiko and colleagues from Harvard, the Harvard Pilgrim Health Care Institute, Brigham and Womens Hospital, Duke University, and the University of Colorado turned to a database of electronic medical records at the University of Colorado Health System that they linked to pharmacy claims
Wang Q, Lin H, Shen C, et al
If youre not completely satisfied with your purchase, dont worry
PlexusDx compounded oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan) and eliminates needle-related pain entirely
IUPHAR reviewglucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target